To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.
(c) 2012 Tom Beer and Larry Axmaker
Showing posts with label Provenge. Show all posts
Showing posts with label Provenge. Show all posts
Jun 5, 2013
Can the immune system remember?
The study we discuss here is not "ready for prime time" but it does report some exciting findings that suggest that immunologic therapy for cancer can produce long term immune memory
To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.
(c) 2012 Tom Beer and Larry Axmaker
To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.
(c) 2012 Tom Beer and Larry Axmaker
Oct 12, 2012
Some Vaccines Have Been Approved to Prevent Cancer-Causing Infections
Several cancervaccines are currently in use and many, many more are in the experimental
stage in clinical trials. Cancer vaccines boost the body’s natural ability to
protect itself through the immune system.
The U.S. Food and Drug
Administration (FDA) has approved two types of preventive cancer vaccines. One
vaccine was designed to prevent Hepatitis B (which can lead to liver cancer)
and another to prevent human papillomavirus types 16 and 18 (HPV) infection and
effectively prevents about 70 percent of cervical cancer.
And just recently (2010) the
FDA approved a vaccine designed to treat (as opposed to prevent) metastatic
prostate cancer in men. It has been used successfully to lengthen survival.
Named sipuleucel-T (Provenge®), it is
individualized to each patient by using immune cells from the patient’s body.
Cancer vaccines may lead to
major improvements in cancer treatment in the future. Some studies to date have
shown positive results and some have not.
If you are interested in
clinical trials for cancer vaccines, check out the list offered on the NCI Factsheet on Cancer Vaccines.
May 9, 2012
Video: Latest Developments in Advanced Prostate Cancer Treatment with Dr. Beer
A comprehensive discussion on all the principal current treatments and the most promising emerging drugs for advanced prostate cancer. In this talk, we discuss hormonal agents including abiraterone and MDV-3100, chemotherapy drugs including docetaxel and cabazitaxel, immunologic therapy with sipuleucel-T, biologic therapy with XL-184, and bone targeted therapy with alpharadin. We then put it altogether to offer a vision for the treatment paradigm of the near future.
For those of you that watched the previously posted talk, this one is a bit more inclusive and comprehensive. It is a different program that was put together with the team at Medscape.
To see the entire program and slides, you will need to go the Medscape website. You will likely need to sign up to be a member of Medscape to get full access to these materials. There is no cost to doing this.
To learn more about clinical trials, take a look at our book.
To put a smile on your face see Larry's latest cartoon.
(c) 2012 Tom Beer and Larry Axmaker
For those of you that watched the previously posted talk, this one is a bit more inclusive and comprehensive. It is a different program that was put together with the team at Medscape.
To see the entire program and slides, you will need to go the Medscape website. You will likely need to sign up to be a member of Medscape to get full access to these materials. There is no cost to doing this.
To learn more about clinical trials, take a look at our book.
To put a smile on your face see Larry's latest cartoon.
(c) 2012 Tom Beer and Larry Axmaker
Subscribe to:
Posts (Atom)